BPA
DARE icon

Beacon Pointe Advisors’s Dare Bioscience DARE Stock Holding History

Beacon Pointe Advisors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-933
Closed -$11.6K – 1099
2023
Q1 		$11.6K Buy
+933
New +$12.4K ﹤0.01% 1134

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Beacon Pointe Advisors's DARE Position: Q2 2023 in Review

Beacon Pointe Advisors sold out of Dare Bioscience (DARE) in Q2 2023, closing a stake of 933 shares — an estimated $11.6K sold.

Beacon Pointe Advisors first reported a position in DARE in Q1 2023 and held it in 1 quarter. The position peaked at $11.6K in Q1 2023. 28 funds tracked by Wall St. Rank hold DARE as of Q2 2023.

  • Beacon Pointe Advisors reported no remaining Dare Bioscience position as of Q2 2023 after selling out during the quarter.
  • Beacon Pointe Advisors sold 933 Dare Bioscience shares in Q2 2023, an estimated $11.6K.
  • Beacon Pointe Advisors first reported a position in Dare Bioscience in Q1 2023 and held it in 1 quarter.
  • Beacon Pointe Advisors's Dare Bioscience position peaked at $11.6K in Q1 2023.
  • 28 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2023.

Based on Beacon Pointe Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.